Exploring the PXR ligand binding mechanism with advanced Molecular Dynamics methods

Stefano Motta1, Lara Callea1, Sara Giani Tagliabue1

  • 1Department of Earth and Environmental Sciences, University of Milano-Bicocca, Milan, Italy.

Scientific Reports
|November 3, 2018
PubMed

Insights

We explored how the SR12813 ligand binds to the Pregnane X Receptor (PXR), revealing its entry pathway, conformational changes, and multiple binding modes using advanced molecular dynamics. This method can study similar complex binding events.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • The Pregnane X Receptor (PXR) is a nuclear receptor that binds various xenobiotics.
  • PXR's diverse binding capabilities make it a significant target for drug discovery.
  • Understanding PXR ligand interactions is crucial for predicting drug efficacy and toxicity.

Purpose of the Study:

  • To investigate the detailed binding mechanism of the SR12813 ligand to PXR.
  • To elucidate ligand entry pathways, conformational alterations, and alternative binding geometries.
  • To demonstrate the utility of advanced computational methods for studying complex ligand-receptor interactions.

Main Methods:

  • Utilized advanced Molecular Dynamics (MD)-based methods within the BiKi suite.
  • Developed specific methodological approaches to address the challenges of a buried and flexible binding cavity.
  • Performed simulations to capture the dynamic process of ligand binding and conformational changes.

Main Results:

  • Provided a comprehensive dynamic description of the SR12813 ligand binding to PXR.
  • Identified the ligand's entrance pathway into the PXR binding cavity.
  • Rationalized the observed multiple binding modes and ligand-induced conformational changes.

Conclusions:

  • The study offers a detailed mechanistic understanding of SR12813-PXR interactions.
  • The employed computational approach is effective for studying complex binding events in nuclear receptors.
  • This methodology can be applied to investigate other challenging ligand-receptor binding processes.

Related Concept Videos

Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.6K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

4.1K
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
15.1K
Ligand Binding Sites02:40

Ligand Binding Sites

8.8K
Extraction: Advanced Methods00:56

Extraction: Advanced Methods

Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
1.2K
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
15.1K